Business
Zealand Pharma continues to strengthen strategic leadership of innovation in obesity and related conditions with appointment of Steven Johnson as Chief Development Officer
Press release – No. 9 / 2025 Zealand Pharma continues to strengthen strategic leadership of innovation in obesity and related conditions with appointment of Steven Johnson as Chief Development Officer Steven will lead the regulatory and development strategies that position Zealand Pharma at the forefront of innovation in the management of obesity and other related complications He joins CMO David Kendall and recently appointed CSO Utpal Singh to strengthen Zealand Pharma’s R&D leadership and pro
About this update from Zealand Pharma A/s
[{"type":"image","alt":"Zealand Pharma","displaySize":"","headline":null,"caption":"Zealand Pharma","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":121,"url":"https://media.zenfs.com/en/globenewswire.com/2567d307984f8639b4a7711f51c64eff"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/6gUCOEdJjLHihlE.VvDQtA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE2OTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/2567d307984f8639b4a7711f51c64eff","width":300,"height":121}},"lazy":false},{"type":"text","content":"Press release – No. 9 / 2025","length":28,"tagName":"p"},{"type":"text","content":"Zealand Pharma continues to strengthen strategic leadership of innovation in obesity and related conditions with appointment of Steven Johnson as Chief Development Officer ","length":171,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Steven will lead the regulatory and development strategies that position Zealand Pharma at the forefront of innovation in the management of obesity and other related complications","length":179,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":179,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"He joins CMO David Kendall and recently appointed CSO Utpal Singh to strengthen Zealand Pharma’s R&D leadership and progress its differentiated clinical pipeline of potential best-in-class peptide therapeutics","length":213,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":213,"olType":false},{"type":"text","content":"Copenhagen, Denmark, May 19, 2025 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announces the appointment of Steven Johnson as Chief Development Officer. Steven will join the executive team to lead regulatory and development strategies at Zealand Pharma. His appointment, alongside Chief Medical Officer, David Kendall and recently appointed Chief Scientific Officer, Utpal Singh further strengthens the company’s strategy to lead the field in innovation in the management of obesity and other related conditions.","length":633,"tagName":"p"},{"type":"text","content":"Steven brings nearly 30 years of experience driving drug development and regulatory strategy across the pharmaceutical industry. He joins Zealand Ph...